214 related articles for article (PubMed ID: 34371870)
61. Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients.
Lyu B; Hansen KE; Jorgenson MR; Astor BC
Am J Nephrol; 2020; 51(6):433-441. PubMed ID: 32485707
[TBL] [Abstract][Full Text] [Related]
62. A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis.
Lewiecki EM; Blicharski T; Goemaere S; Lippuner K; Meisner PD; Miller PD; Miyauchi A; Maddox J; Chen L; Horlait S
J Clin Endocrinol Metab; 2018 Sep; 103(9):3183-3193. PubMed ID: 29931216
[TBL] [Abstract][Full Text] [Related]
63. Is trabecular bone score less affected by degenerative-changes at the spine than lumbar spine BMD?
Anderson KB; Holloway-Kew KL; Mohebbi M; Kotowicz MA; Hans D; Pasco JA
Arch Osteoporos; 2018 Nov; 13(1):127. PubMed ID: 30446835
[TBL] [Abstract][Full Text] [Related]
64. The effect of zoledronic acid on hip geometry in renal transplant recipients: a double-blind placebo-controlled randomized study.
Dabbaghmanesh A; Bakhshayeshkaram M; Roshanzamir S; Naseri A; Dabbaghmanesh MM; Heydari ST; Talehzadeh P; Dabbaghmanesh MH; Jahromi SE
BMC Nephrol; 2023 Nov; 24(1):331. PubMed ID: 37940839
[TBL] [Abstract][Full Text] [Related]
65. Marine n-3 Polyunsaturated Fatty Acid Supplementation and Quality of Life After Kidney Transplant.
Aasebø W; Svensson M; Jenssen T; Eide IA
Transplant Proc; 2019 Mar; 51(2):466-469. PubMed ID: 30879569
[TBL] [Abstract][Full Text] [Related]
66. n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease.
Barden A; O'Callaghan N; Burke V; Mas E; Beilin LJ; Fenech M; Irish AB; Watts GF; Puddey IB; Huang RC; Mori TA
Nutrients; 2016 Mar; 8(3):175. PubMed ID: 27007392
[TBL] [Abstract][Full Text] [Related]
67. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
[TBL] [Abstract][Full Text] [Related]
68. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats.
Watkins BA; Li Y; Seifert MF
J Nutr Biochem; 2006 Apr; 17(4):282-9. PubMed ID: 16102959
[TBL] [Abstract][Full Text] [Related]
69. Vitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial.
Levy-Schousboe K; Marckmann P; Frimodt-Møller M; Peters CD; Kjærgaard KD; Jensen JD; Strandhave C; Sandstrøm H; Hitz MF; Langdahl B; Vestergaard P; Brasen CL; Schmedes A; Madsen JS; Jørgensen NR; Frøkjær JB; Frandsen NE; Petersen I; Hansen D
Nephrol Dial Transplant; 2023 Sep; 38(10):2131-2142. PubMed ID: 36460034
[TBL] [Abstract][Full Text] [Related]
70. Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate.
Trombetti A; Gerbase MW; Spiliopoulos A; Slosman DO; Nicod LP; Rizzoli R
J Heart Lung Transplant; 2000 Aug; 19(8):736-43. PubMed ID: 10967266
[TBL] [Abstract][Full Text] [Related]
71. Inverse Association Between Serum Osteoprotegerin and Bone Mineral Density in Renal Transplant Recipients.
Hsu BG; Chen YC; Ho GJ; Shih MH; Chou KC; Lin TY; Lee MC
Transplant Proc; 2016 Apr; 48(3):864-9. PubMed ID: 27234754
[TBL] [Abstract][Full Text] [Related]
72. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
Roe SD; Porter CJ; Godber IM; Hosking DJ; Cassidy MJ
Osteoporos Int; 2005 Feb; 16(2):142-8. PubMed ID: 15258722
[TBL] [Abstract][Full Text] [Related]
73. Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.
Dasarathy S; Dasarathy J; Khiyami A; Yerian L; Hawkins C; Sargent R; McCullough AJ
J Clin Gastroenterol; 2015 Feb; 49(2):137-44. PubMed ID: 24583757
[TBL] [Abstract][Full Text] [Related]
74. Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study.
Popp AW; Guler S; Lamy O; Senn C; Buffat H; Perrelet R; Hans D; Lippuner K
J Bone Miner Res; 2013 Mar; 28(3):449-54. PubMed ID: 23018784
[TBL] [Abstract][Full Text] [Related]
75. Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
van Bodegraven AA; Bravenboer N; Witte BI; Dijkstra G; van der Woude CJ; Stokkers PC; Russel MG; Oldenburg B; Pierik M; Roos JC; van Hogezand RA; Dik VK; Oostlander AE; Netelenbos JC; van de Langerijt L; Hommes DW; Lips P;
Gut; 2014 Sep; 63(9):1424-30. PubMed ID: 24146170
[TBL] [Abstract][Full Text] [Related]
76. [Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases : Correlation with conventional bone mineral density measurement and prevalence of vertebral fractures].
Buehring B; Thomas J; Wittkämper T; Baraliakos X; Braun J
Z Rheumatol; 2020 Dec; 79(10):1067-1074. PubMed ID: 32162022
[TBL] [Abstract][Full Text] [Related]
77. Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study.
Krieg MA; Seydoux C; Sandini L; Goy JJ; Berguer DG; Thiébaud D; Burckhardt P
Osteoporos Int; 2001; 12(2):112-6. PubMed ID: 11303710
[TBL] [Abstract][Full Text] [Related]
78. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study.
Cruz DN; Wysolmerski JJ; Brickel HM; Gundberg CG; Simpson CA; Mitnick MA; Kliger AS; Lorber MI; Basadonna GP; Friedman AL; Insogna KL; Bia MJ
Transplantation; 2001 Jul; 72(1):83-8. PubMed ID: 11468539
[TBL] [Abstract][Full Text] [Related]
79. Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.
Haas M; Leko-Mohr Z; Roschger P; Kletzmayr J; Schwarz C; Mitterbauer C; Steininger R; Grampp S; Klaushofer K; Delling G; Oberbauer R
Kidney Int; 2003 Mar; 63(3):1130-6. PubMed ID: 12631097
[TBL] [Abstract][Full Text] [Related]
80. Effect of compression fracture on trabecular bone score at lumbar spine.
Hsu Y; Hsieh TJ; Ho CH; Lin CH; Chen CK
Osteoporos Int; 2021 May; 32(5):961-970. PubMed ID: 33104822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
